15:45 , Mar 28, 2018 |  BC Innovations  |  Distillery Techniques

Drug platforms

TECHNOLOGY: Cell therapy A 3-D cell culture system could generate naïve T cell-like cells for use as adoptive T cell therapies. The model involves two steps: culturing mouse iPS cells in the presence of the...
23:57 , Jul 13, 2017 |  BC Week In Review  |  Company News

ADC Therapuetics options one Chiome antibody, declines another

Chiome Bioscience Inc. (Tokyo:4583) said it received notification from ADC Therapeutics S.A. (Epalinges, Switzerland) that ADC intends to exercise its option to negotiate rights to LIV-1205 . The exclusive, worldwide rights would cover the development...
18:02 , Feb 15, 2017 |  BC Innovations  |  Distillery Therapeutics

Hematology

INDICATION: Immunodeficiency Mouse studies suggest transplant of engineered hematopoietic stem cells (HSCs) could help treat immunodeficiency. The HSCs consisted of HOXB4 -expressing mouse embryonic stem cell (ESC)-derived HSCs that had been co-cultured with a DLL1...